Can Anyone Keep a Patent over Human Genes?

Can Anyone Keep a Patent over Human Genes? A judge on Tuesday weighed whether a lawsuit ought to proceed that seeks to invalidate a company’s patents on two genes linked to an increased threat of breast and ovarian malignancy. The case challenging whether anyone can take patents on human genes has broad implications for the biotechnology industry and genetics-based medical study . Last March, the American Civil Liberties Union and the Public Patent Basis sued Myriad Genetics Inc., the University of Utah Research Base and the U.S. Patent and Trademark Workplace in U.S. District Court in Manhattan. The ACLU and the patent base say Myriad’s refusal to license the patents broadly provides meant that ladies who fear they may be vulnerable to breast or ovarian tumor are avoided from having anyone but Myriad consider the genes in question.


Obstacles to treatment are widespread: the most obvious being that across the United States nearly 13 million females of reproductive age , or one in five, have no medical health insurance. In California, 20.9 % of eligible women are uninsured; among women of color the real number of uninsured climbs to 28.5 %. The state’s Medicaid eligibility level for operating parents is also suprisingly low, $18,672. Lack of access to healthcare centers and suppliers is a nagging problem nationwide, the report found; in California 49 % of women live in medically underserved areas. ‘The federal government should accept its duty and its moral obligation to address this inexcusable crisis by developing a comprehensive plan to ensure quality healthcare for all pregnant women.

Other entries from category "diagnostics":

Random entries